Related Experiment Videos
Exercise plays a preventive role against Alzheimer's disease
Zsolt Radak1, Nikoletta Hart, Linda Sarga
1Research Institute of Sport Science, Faculty of Physical Education and Sport Science, Semmelweis University, Budapest, Hungary. radak@mail.hupe.hu
Journal of Alzheimer'S Disease : JAD
|February 26, 2010
Summary
Regular physical activity can help prevent Alzheimer's disease (AD). Exercise boosts brain health by improving cellular endurance, vascularization, and neurotrophin synthesis, crucial for memory and plasticity.
Area of Science:
- Neuroscience
- Gerontology
- Preventive Medicine
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder impacting the elderly.
- Projected increases in AD incidence present significant global health and economic challenges.
- AD pathology involves oxidative stress, amyloid plaques, and tau tangles in the brain.
Purpose of the Study:
- To provide an overview of the beneficial effects of exercise on Alzheimer's disease.
- To highlight exercise's role in mitigating AD risk factors and progression.
Main Methods:
- This study is an overview based on existing research.
- Analysis of scientific literature on exercise and neurodegenerative disorders.
Main Results:
- Physical activity enhances cellular and tissue resistance to oxidative stress.
- Exercise improves vascularization, energy metabolism, and neurotrophin synthesis.
- These physiological changes support neurogenesis, memory enhancement, and brain plasticity.
Conclusions:
- Physical exercise demonstrates clear benefits in preventing Alzheimer's disease.
- Exercise positively impacts key mechanisms underlying neuroprotection and cognitive function.
- Further research is needed to fully elucidate the mechanisms of exercise's protective effects.
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...